Mind Medicine Inc (NASDAQ: MNMD) on Friday, plunged -9.20% from the previous trading day, before settling in for the closing price of $9.78. Within the past 52 weeks, MNMD’s price has moved between $4.70 and $11.02.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12.11% over the past five years. The company achieved an average annual earnings per share of -14.70%. With a float of $72.52 million, this company’s outstanding shares have now reached $75.80 million.
Mind Medicine Inc (MNMD) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mind Medicine Inc is 4.01%, while institutional ownership is 54.47%. The most recent insider transaction that took place on Jun 25 ’25, was worth 78,139. In this transaction Chief Legal Officer of this company sold 11,491 shares at a rate of $6.80, taking the stock ownership to the 305,130 shares. Before that another transaction happened on Jun 25 ’25, when Company’s Chief Medical Officer sold 7,848 for $6.80, making the entire transaction worth $53,366. This insider now owns 438,329 shares in total.
Mind Medicine Inc (MNMD) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.18 earnings per share (EPS) for the period topping the consensus outlook (set at -0.26) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -14.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 1.12% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Mind Medicine Inc (MNMD) is currently performing well based on its current performance indicators. A quick ratio of 4.98 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -1.85 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Mind Medicine Inc (NASDAQ: MNMD) saw its 5-day average volume 1.65 million, a positive change from its year-to-date volume of 1.5 million. As of the previous 9 days, the stock’s Stochastic %D was 27.19%.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 66.14%, which indicates a significant increase from 7.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.58 in the past 14 days, which was higher than the 0.48 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.78, while its 200-day Moving Average is $7.46. Nevertheless, the first resistance level for the watch stands at $9.59 in the near term. At $10.29, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.74. If the price goes on to break the first support level at $8.44, it is likely to go to the next support level at $7.99. Assuming the price breaks the second support level, the third support level stands at $7.29.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
Market capitalization of the company is 675.66 million based on 76,088K outstanding shares. Right now, sales total 0 K and income totals -108,680 K. The company made 0 K in profit during its latest quarter, and -42,740 K in sales during its previous quarter.
